5173 POSTER Bcl2 Expression Predicts Clinical Outcome of Combined Targeted Therapies of HER2+/ER+ and the Potential Benefit of Anthracycline-based Chemotherapy of HER2+ Breast Cancer (BC)

✍ Scribed by Abdel-Fatah, T.M.; Barros, F.; Green, A.; Dickinson, P.; Moseley, P.; Ian, O.E.; Chan, S.

• Book ID: 122767225
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 40 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71615-X